tofersen and the fda approval process
Published 1 year ago • 1.4K plays • Length 57:05Download video MP4
Download video MP3
Similar videos
-
25:47
tofersen and the future of als drug development
-
30:04
why fda decision on tofersen matters
-
2:39
oral testimony to the fda advisory committee on the approval of tofersen
-
5:48
fda approves biogen’s tofersen drug for rare form of als
-
1:32
tofersen (qalsody), first fda approved medication for sod1-als (amyotrophic lateral sclerosis)
-
27:23
fda advisory committee to consider tofersen
-
2:31
treatment updates in als: edaravone, amx0035, and tofersen
-
10:59
the brewing fda battle over als treatment
-
0:49
tofersen approved for sod1-als
-
4:28
understanding tofersen’s impact on sod1 als, neurofilament light
-
2:11
fda approves drug for als treatment
-
4:50
breaking: fda approves qalsody for als
-
1:07
qalsody fda approval
-
2:18
7 generations battling als: rockford family's new hope with experimental drug
-
2:40
tofersen helps people with als caused by an sod1 mutation
-
0:46
a beacon of hope: qalsody's mission to conquer als!
-
25:49
updates in amyotrophic lateral sclerosis (als)
-
19:09
fda approved therapy for sod1 associated als
-
25:42
2021 neuroscience symposium | breaking update: als clinical trials